Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
07/2003
07/31/2003US20030144265 HIV protease inhibitors based on amino acid derivatives
07/31/2003US20030144217 Prodrugs of aspartyl protease inhibitors
07/31/2003US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
07/31/2003CA2473545A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/30/2003EP1331221A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
07/30/2003EP1330233A1 Method of treating stroke
07/30/2003CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid
07/29/2003US6600072 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic , and medicament containing them
07/29/2003US6599942 Method of lowering LDL cholesterol and Lipoprotein a levels in mammals using such compounds
07/29/2003CA2247398C Herbicidal sulfonamide derivatives
07/29/2003CA2188690C Selective thrombin inhibitors
07/24/2003WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives
07/24/2003WO2003059870A1 N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same
07/24/2003US20030139627 Enantioselective production of an optically active amino compound by amination of the C-H bond of an organic compound
07/24/2003US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer
07/24/2003US20030139475 Novel tricyclic compounds and drug compositions containing same
07/24/2003US20030139390 Compounds for the modulation of PPARgamma activity
07/24/2003US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders
07/23/2003EP1328518A1 Imidazolium salts and the use of these ionic liquids as a solvent
07/23/2003EP1328510A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
07/23/2003CN1432000A TNF-alpha prodn. inhibitors
07/23/2003CN1431037A 3 oxide heteroperfluoro-nonyl fluorocarbon surfactant, its systhesizing method and usages
07/23/2003CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives
07/22/2003US6596878 Protein kinase inhibitor compositio; used to treat cell proliferative disorders such as cancers charcterized by over-activity or inappropriate activity HER2 or EGFR.
07/22/2003US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
07/22/2003US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are
07/22/2003US6596752 Inhibitors of α4β1 mediated cell adhesion
07/22/2003US6596716 2-propane-sulphonamide derivatives
07/17/2003WO2003057665A1 Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same
07/17/2003WO2003057255A1 Drugs against obeisty and drugs against fatty liver
07/17/2003WO2003057254A1 Preventives/remedies for urinary disturbance
07/17/2003WO2003057169A2 4-dedimethylamino tetracycline compounds
07/17/2003US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor
07/17/2003US20030135055 Inhibitors of factors Xa and VIIa
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/17/2003US20030133904 Sphingolipids
07/17/2003CA2472133A1 Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same
07/17/2003CA2471760A1 Preventives/remedies for urinary disturbance
07/16/2003CN1430600A 7-and 9-carbamate, urea, thiourea, thiocarbamate and heteroaryl-amino substituted tetracycline compounds
07/15/2003US6593363 The present invention relates to diterpene derivatives prepared from the components which are extracted from Acanthopanax Koreanum and represented by Chemical Formula (1).
07/15/2003US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/15/2003US6593019 Ionically conducting materials, electrolytes and selective membranes
07/10/2003WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
07/10/2003WO2003055847A1 Carboxylic acid derivative
07/10/2003WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
07/10/2003WO2001098248A3 Hiv integrase inhibitors
07/10/2003US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/10/2003US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
07/10/2003CA2482392A1 Carboxylic acid derivative
07/09/2003EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
07/09/2003EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
07/09/2003EP1324979A2 Ionic liquids and their use as solvents
07/09/2003EP1324970A2 Retinoids for the treatment of emphysema
07/09/2003EP1233939A4 Process for preparing optically active alpha-hydroxy acids and derivatives thereof
07/09/2003CN1429206A 磺酰胺衍生物 Sulfonamide derivatives
07/09/2003CN1429205A 磺酰胺衍生物 Sulfonamide derivatives
07/09/2003CN1429204A Process for preparing biphenyl compounds
07/09/2003CN1429108A 磷酸盐运输抑制剂 Phosphate transport inhibitor
07/09/2003CN1113862C Arysulfonylamino hydroxamic acid derivs.
07/08/2003US6590118 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes)
07/08/2003US6590105 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits
07/08/2003US6589972 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
07/08/2003CA2135290C Abrasion-resistant coating composition and abrasion resistant energy control sheet
07/03/2003WO2003053919A1 Substituted cyclohexane derivatives
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS
07/03/2003WO2003053435A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/03/2003US20030125559 Methods for synthesizing ether compounds and intermediates therefor
07/03/2003US20030125556 Having an aryl group bonded to a carbon atom in an azomethine moiety and containing amido and amine groups; useful for silver halide photographic photosensitive materials and for printing material in ink jet or thermal printing
07/03/2003US20030125365 Inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125348 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125315 Providing a focused approach that permits a more rapid screening of probes with potential for association with a particular binding site with a higher likelihood of success; combinatorial chemistry; screening; computer software
07/03/2003CA2470964A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/02/2003EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists
07/02/2003EP1322602A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds
07/02/2003EP1322599A2 Hiv integrase inhibitors
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP0944582B1 Ketobenzamides as calpain inhibitors
07/02/2003CN1427818A Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use
07/01/2003US6586617 Sulfonamide derivatives
07/01/2003US6586475 5-chloro-N-(2-N,N-diethylamino)ethyl)-2- methoxy-4-(1-naphthoylamino)benzamide and prodrugs, used for prevention of neurodegenarative diseases such as Alzheimer's disease
07/01/2003US6586467 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus
07/01/2003US6586466 Carbohydrazide-protease inhibitors
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
06/2003
06/26/2003WO2003051894A1 Preparation of ionic liquids
06/26/2003WO2003051865A1 Dioxathianones
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051825A1 Human adam-10 inhibitors
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119876 Compounds for the treatment of protozoal diseases
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119803 In particular N-epsilon-amino acid substituted L-lysine derivatives possessing aspartyl protease inhibitory properties.
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003CA2473938A1 Human adam-10 inhibitors
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 177